9th World Congress on Rare Diseases and Orphan Drugs, Berlin (2019)

3.0 from 2 votes
Date: 17 - 18 June, 2019
Location: Berlin, Germany

About Conference

We are happy to announce this, with the success of previous Rare Diseases Congress series, we are delighted to invite all the participants over the globe to attend "9th World Congress on Rare Diseases and Orphan Drugs", will be held during June 17-18, 2019 at Berlin, Germany which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions in the field of Rare Diseases and Orphan Drugs.

Rare Diseases refer to those medical aberrations which affect a very least number of the population. They are characterized by a wide diversity of disorders and symptoms that differs not only from disease to disease but also from individual to individual patient suffering from the same disease. About 80% of these disorders have predictable genetic origins while the others are the result of infections, allergies, neurological related and environmental causes. A medicinal product developed for the treatment of a Rare Disease is an Orphan Drug. Under regular market environments the pharmaceutical industry has little attention in evolving and marketing products of Orphan Drugs proposed for only a small number of patients.

The conference conquers implication when we look at the worldwide deaths due to Rare Diseases. The majority of around 800 million people with other Rare Diseases, including 100,000 children born with thalassaemia annually receive no treatment. There are major ethical quandaries in dealing with global health issues such as the treatment of Orphan and Rare Diseases.

Target Audience:


Infectious Diseases Specialists



Health Care Professionals






Researcher Scholars

Training Institutes

Pharmaceutical Companies

Rare Diseases Associations

Orphan Drugs Companies


Why to attend?

Rare Diseases and Orphan Drugs conference signifies serious uncommon/ unrelated complications that have diverse impacts on people, public health, and economies. These diseases are responsible for rising healthcare costs, lost productivity, and long-term disability. This conference will feature a global audience of scientific leaders, academia and health care professionals, and Orphan Drugs experts who are going to discuss today's emerging treatments and diagnostics. By bringing together the Rare Diseases community, presenting the latest developments, and identifying unmet treatment needs, Rare Diseases Congress-2019 hopes to accelerate research and drug development in Rare Diseases, improving patient outcomes. It is designed to provide an educational forum that stimulates clinical, research, government and patient communities to create a coordinated and comprehensive approach for advancing the implementation of research, clinical care, care delivery coordination and other public health interventions critical to improved outcomes in Rare Diseases and Orphan Drugs research.

For Scientific Sessions please go through the link:

For Abstract Submission please go through the link:

For Topics please go through the link:

3.0 from 2 votes